Perspectives
AMCP 2024: Behind the research with YuQian Liu
Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of this exciting frontier
April 17, 2024As more high-priced cell and gene therapies come onto the market, the health care industry is faced with a fundamental challenge: to make sure that patients can access these life-saving treatments.
That was the focus of the day two session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting, “Future of Cell and Gene Therapy Management: There is More Than Value Based Contracting!”
We caught up with one of the presenters, YuQian Liu, senior director of specialty clinical solutions at Prime Therapeutics/Magellan Rx, to talk about how managed care pharmacy professionals can rise to this challenge.
Stay tuned for additional coverage from AMCP Annual 2024 on our newsroom, and follow us on LinkedIn or X (formerly Twitter).
Related news
Perspectives
July 25, 2024
Quarterly Drug Pipeline: July 2024
Clinical insights and competitive intelligence on anticipated drugs in development
Perspectives
July 22, 2024
Oncology Insights: 2024 ASCO Annual Meeting key findings
Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions
Perspectives
July 16, 2024
LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast
In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts